Product Information
SUMATRIPTAN 20 MG NASAL SPRAY is a generic product labeled by Prasco Laboratories, priced at $16.5061 per EA under NDC 66993008269. Its NADAC has been published 317 times since Sep 9, 2020.
FDA first approved this application on Aug 26, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/100uL
Manufacturer
Prasco LaboratoriesNDC
66993008269
Classification
Generic
Dosage Form
SPRAY
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
SUMATRIPTANApproval Type
Authorized Generic (NDA)
FDA Application
NDA020626FDA Approved
8/26/1997
TE Code
AB
On Market Since
7/1/2020
Pharmacological Classes
Price Statistics
The NADAC for SUMATRIPTAN 20 MG NASAL SPRAY has been published 317 times since Sep 9, 2020, and over the history we have for it it has declined 57.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.5061 per EA |
|---|---|
| All-time high | $45.7134 (Jan 13, 2021) |
| All-time low | $13.8657 (Nov 20, 2024) |
| 52-week high | $17.6932 |
| 52-week low | $15.8842 |
| Median price | $19.8486 |
| Average price | $23.2256 |
| Largest weekly change | -38.3% (Nov 20, 2024) |
| Weeks tracked | 317 |
| Tracking since | Sep 9, 2020 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Prasco Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
sumatriptan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SUMATRIPTAN 20 MG NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN 20 MG NASAL SPRAY, manufactured by Prasco Laboratories, is $16.5061 per EA (NDC 66993008269), effective Sep 30, 2026.
How has the price of SUMATRIPTAN 20 MG NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for SUMATRIPTAN 20 MG NASAL SPRAY has declined 57.7%. It has been tracked across 317 weekly CMS publications since Sep 9, 2020.
What are the highest and lowest recorded NADAC prices for SUMATRIPTAN 20 MG NASAL SPRAY?
Since Sep 9, 2020, the NADAC for SUMATRIPTAN 20 MG NASAL SPRAY has ranged from a low of $13.8657 (Nov 20, 2024) to a high of $45.7134 (Jan 13, 2021), with a median of $19.8486 per EA.
Are there cheaper alternatives to SUMATRIPTAN 20 MG NASAL SPRAY?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SUMATRIPTAN 20 MG NASAL SPRAY, is $15.9964 per EA — about 3% below SUMATRIPTAN 20 MG NASAL SPRAY.
Who manufactures SUMATRIPTAN 20 MG NASAL SPRAY?
SUMATRIPTAN 20 MG NASAL SPRAY (NDC 66993008269) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.